The stock of Danimer Scientific Inc. (NYSE:DNMR) decreased by -$0.02 on Friday to finish at $2.14, down -0.93 percent. The last five days have seen an average of 1,002,840 shares of common stock traded. 16 times new highs were reached in the current year, with a gain of $0.35. The average number of shares traded over the last 20 days was 853,855, while the average volume over the last 50 days totaled 959,276.
DNMR stock dropped -26.71% since last month. On 08/11/23, the company’s shares reached a one-month low of $2.10. The stock touched a high of $5.79 on 04/04/23, after rallying from a low of $1.57 in 52 weeks. The price of DNMR stock has risen by 19.55% or $0.35 this year, reaching a new high 16 times. Still, the stock price is down -63.04% from the 52-week high.
Insider Transactions
DNMR stock investors should be aware that Danimer Scientific Inc. (DNMR) stock had its last reported insider trading activity 55 days ago on Jun 20. On Jun 20, Chief Marketing Officer Tuten Scott sold 10,000 shares at $2.74 each. This transaction resulted in the insider making $27,390. On May 17, Tuten Scott sold 10,000 shares at a price of US$3.38. After the transaction, the insider now owns 356,478 shares. Chief Marketing Officer Tuten Scott had earlier sold 10,000 shares on Apr 17 for $4.26 a share. The transaction was completed for $42,619.
Valuation Metrics
Beta for the stock is 1.45. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.37, the price-to-book (PB) ratio of 0.61.
Financial Health
For the three months ended June 29, Danimer Scientific Inc.’s quick ratio was 5.90, while its current ratio was 7.20, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 1.05, and the total debt to equity ratio is 1.07. As far as profitability goes, gross margin for the trailing twelve months is -27.90% percent. Based on annual data, it had gross profit of -$10.41 million and revenue of $53.22 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. DNMR’s return on assets (ROA) during the last 12 months has been -23.80%. There was a -28.20% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -45.00%.
Earnings Surprise
According to Danimer Scientific Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $12.87 million, while revenues rose by 1.32% to $11.93 million. It was predicted that Danimer Scientific Inc.’s quarterly earnings would be -$0.38, but it ended up being -$0.36, beating the consensus by -5.60%. EBITDA was -$21.33 million for the quarter. At the end of Danimer Scientific Inc.’s most recent quarter ended June 29, its liabilities totaled 413.97 million, while its total debt was $403.18 million. Equity owned by shareholders amounts to $102.03 million.
Technical Picture
Here’s a quick look at Danimer Scientific Inc.’s (DNMR) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 25.46%, suggesting the stock is oversold, with a 71.29% historical volatility rate.
The stochastic %K and %D were 7.63% and 11.62% respectively, while the average true range (ATR) was 0.19. Based on the 14-day stochastic reading of 4.88%, the RSI (14) reading is 32.28%. On the 9-day MACD Oscillator, the stock is at -0.22, and the 14-day reading is at -0.35.
Analyst Ratings
In its analyst report released on October 12, 2022, Piper Sandler began covering Danimer Scientific Inc. (NYSE: DNMR). The stock was rated as an Overweight by the brokerage firm. Analysts have assigned Danimer Scientific Inc. (DNMR) an Buy rating. DNMR is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is DNMR’s price target for the next 12 months?
The current consensus forecast for the stock is between $2.75 and $8.00, with a median target price of $4.75. In analyzing these forecasts, the average price target given by analysts for Danimer Scientific Inc. (DNMR) is $5.10.
